These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2189328)

  • 21. [Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance].
    Jenzer G; Bremgartner MF
    Schweiz Rundsch Med Prax; 1990 Aug; 79(31-32):914-7. PubMed ID: 2203127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
    Pradalier A; Guérard des Lauriers A; Scheck F; Peraudeau P; Lacoste JP; Cajfinger F
    Pathol Biol (Paris); 1995 Nov; 43(9):806-13. PubMed ID: 8746103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study].
    Langohr HD; Reinecke M; Gerber WD; Mangold R
    Fortschr Med; 1988 Jan; 106(2):65-6, 69-70. PubMed ID: 3278960
    [No Abstract]   [Full Text] [Related]  

  • 24. DHE in the pharmacotherapy of migraine: potential for a larger role.
    Saper JR; Silberstein S; Dodick D; Rapoport A
    Headache; 2006 Nov; 46 Suppl 4():S212-20. PubMed ID: 17078853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Double blind study of migraine therapy with etilefrine pivalate].
    Cruz A; Bühling M; Seibel K
    Arzneimittelforschung; 1985; 35(7):1086-9. PubMed ID: 2864937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The long term use of dihydroergotamine (DHE-45) in migraine treatment (author's transl)].
    Miyazaki T
    Masui; 1978 Jan; 27(1):79-84. PubMed ID: 633616
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of migraine using flunarizine (results of a pilot study using Amalium)].
    Wessely P; Holzner F
    Wien Med Wochenschr; 1987 Jan; 137(1):21-6. PubMed ID: 3590812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug treatment of migraine in children: state of the art].
    Cuvellier JC; Joriot S; Auvin S; Vallée L
    Arch Pediatr; 2004 May; 11(5):449-55. PubMed ID: 15135430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic drugs and cytokine and leptin levels in children with migraine.
    Hirfanoglu T; Serdaroglu A; Gulbahar O; Cansu A
    Pediatr Neurol; 2009 Oct; 41(4):281-7. PubMed ID: 19748048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flunarizine in the prevention of the migraine crisis of classic and common headache].
    Pini LA; Ferrari A; Bergonzini G; Sternieri E
    Minerva Med; 1987 Jul; 78(14):1097-8. PubMed ID: 3601158
    [No Abstract]   [Full Text] [Related]  

  • 33. Flunarizine in the treatment of migraine: state of the art. Symposium to the 3rd congress of the International Headache Society. Florence, September 23, 1987. Proceedings.
    Cephalalgia; 1988; 8 Suppl 8():1-40. PubMed ID: 3180196
    [No Abstract]   [Full Text] [Related]  

  • 34. [Severe case of basilar migraine treated with flunarizine].
    Pierzchała K; Rościszewska D; Kwieciński J
    Neurol Neurochir Pol; 1992; 26(6):879-82. PubMed ID: 1301516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flunarizine (Sibelium) in the prophylaxis of migraine. An open, long-term, multicenter trial.
    Martínez-Lage JM
    Cephalalgia; 1988; 8 Suppl 8():15-20. PubMed ID: 3052850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preventive effect of behavioral therapy plus flunarizine in children with migraine].
    Chen YZ; Li N; Zhou KY
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1105-8. PubMed ID: 25406552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels.
    Centonze V; Magrone D; Vino M; Caporaletti P; Attolini E; Campanale G; Albano O
    Cephalalgia; 1990 Feb; 10(1):17-24. PubMed ID: 2317849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flunarizine plasma concentrations and side effects in migraine patients.
    Albani F; Baldrati A; Cortelli P; Riva R; Baruzzi A
    Headache; 1990 May; 30(6):369-70. PubMed ID: 2370140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alternating hemiplegia. Partial effectiveness of treatment with flunarizine].
    Alvarez Gómez MJ; Narbona García J; Barona Zamora P
    Neurologia; 1992 Mar; 7(3):116-9. PubMed ID: 1571184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flunarizine i.v. in the acute treatment of common or classical migraine attacks--a placebo-controlled double blind trial.
    Soyka D; Taneri Z; Oestreich W; Schmidt R
    Headache; 1989 Jan; 29(1):21-7. PubMed ID: 2647666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.